Delivery Order SPE2DR25D2001-SPE2DR26FBFU6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,194.80 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL vials (10mL) under a firm fixed-price contract. The award, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a competitively awarded non-set-aside procurement. Performance of this delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,736.48 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Insulin Aspart 100 Unit/mL in 10mL vials. The award represents a competitive, non-set-aside contract with firm fixed pricing and a completion date of December 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,416.40 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Insulin Aspart 100 Unit/mL in 10mL vials. This is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.42 on August 19, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL). This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL vials (10 mL) with a ceiling value of $7,392.40. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The award was made on October 29, 2025, with an ultimate completion date of October 30, 2025. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,989.67 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL vials (10mL) on October 20, 2025, with completion targeted for October 21, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL vials (10mL) valued at $2,843.25 on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside, firm fixed price delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,772.30 delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/ML vials (10 ML) on November 20, 2025, with an ultimate completion date of November 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a delivery order valued at $1,699.68 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL in 10mL vials. This non-competitive, firm fixed price delivery order was awarded on December 1, 2025, with an ultimate completion date of December 2, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child delivery order issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10 mL) with a ceiling value of $1,463.20. This is a firm fixed price delivery order with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBFU6Delivery Order
The Defense Logistics Agency has awarded a delivery order valued at $2,671.90 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/ML in 10 ML vials. This firm fixed price delivery order, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The award is unset-aside and competitively awarded, reflecting AmerisourceBergen's established capability as a critical pharmaceutical distributor for federal medical procurement. Performance will be executed from the company's Conshohocken, Pennsylvania location, where the corporate office is headquartered. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The arrangement demonstrates the company's role as a critical vendor within the Defense Health Agency's medical supply chain, providing essential pharmaceuticals to sustain military medical readiness and support veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/4/25 |